Risk Factors for Acute Cholangitis Caused by
Anti-microbial agents
Cholangitis
Sphincterotomy
Therapeutics
Journal
Gut and liver
ISSN: 2005-1212
Titre abrégé: Gut Liver
Pays: Korea (South)
ID NLM: 101316452
Informations de publication
Date de publication:
15 07 2021
15 07 2021
Historique:
received:
11
07
2020
revised:
25
09
2020
accepted:
05
10
2020
pubmed:
29
12
2020
medline:
25
2
2023
entrez:
28
12
2020
Statut:
ppublish
Résumé
Acute cholangitis (AC) is a potentially life-threatening bacterial infection, and timely antimicrobial treatment, faster than that achieved with bacterial cultures, is recommended. Although the current guidelines refer to empirical antimicrobial treatment, various kinds of antimicrobial agents have been cited because of insufficient analyses on the spectrum of pathogens in AC. Patients with AC who were hospitalized in a Japanese tertiary center between 2010 and 2015 were retrospectively analyzed. Patients' first AC episodes in the hospital were evaluated. A total of 266 patients with AC were identified. Given the intrinsic resistance of
Sections du résumé
Background/Aims
Acute cholangitis (AC) is a potentially life-threatening bacterial infection, and timely antimicrobial treatment, faster than that achieved with bacterial cultures, is recommended. Although the current guidelines refer to empirical antimicrobial treatment, various kinds of antimicrobial agents have been cited because of insufficient analyses on the spectrum of pathogens in AC.
Methods
Patients with AC who were hospitalized in a Japanese tertiary center between 2010 and 2015 were retrospectively analyzed. Patients' first AC episodes in the hospital were evaluated.
Results
A total of 266 patients with AC were identified.
Conclusions
Given the intrinsic resistance of
Identifiants
pubmed: 33361547
pii: gnl20214
doi: 10.5009/gnl20214
pmc: PMC8283283
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-624Références
Microb Drug Resist. 2003 Summer;9(2):167-74
pubmed: 12820802
Clin Infect Dis. 2002 Apr 1;34(7):922-9
pubmed: 11880957
Surg Clin North Am. 1990 Dec;70(6):1297-312
pubmed: 2247816
J Infect. 2013 Aug;67(2):111-21
pubmed: 23603487
Microb Drug Resist. 2009 Mar;15(1):1-9
pubmed: 19216682
Clin Microbiol Infect. 2014 Feb;20(2):145-51
pubmed: 23647880
Clin Infect Dis. 2004 Aug 1;39(3):309-17
pubmed: 15306996
Gut Liver. 2011 Mar;5(1):1-14
pubmed: 21461066
Ann Clin Microbiol Antimicrob. 2017 Jul 12;16(1):50
pubmed: 28701170
J Infect. 2010 Jul;61(1):34-43
pubmed: 20433865
J Clin Microbiol. 1992 Sep;30(9):2373-8
pubmed: 1401001
Surg Infect (Larchmt). 2011 Apr;12(2):105-11
pubmed: 21348769
J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):60-70
pubmed: 23340954
J Antimicrob Chemother. 2016 Dec;71(12):3453-3458
pubmed: 27609052
Clin Infect Dis. 2004 Jan 1;38(1):53-61
pubmed: 14679448
J Clin Microbiol. 1989 Apr;27(4):731-4
pubmed: 2656745
Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E320-6
pubmed: 25631594
Infect Control Hosp Epidemiol. 2009 Feb;30(2):184-6
pubmed: 19125679
Ann Surg. 1989 Apr;209(4):435-8
pubmed: 2930289
J Surg Res. 1994 Aug;57(2):316-36
pubmed: 8028341
J Med Microbiol. 2007 Nov;56(Pt 11):1549-1557
pubmed: 17965358
Aliment Pharmacol Ther. 2015 Jul;42(2):212-20
pubmed: 25997554
PLoS One. 2017 Jan 11;12(1):e0169900
pubmed: 28076388
J Infect Chemother. 2018 May;24(5):330-340
pubmed: 29555391
Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):533-41
pubmed: 19652653
J Infect. 2015 May;70(5):483-90
pubmed: 25659761
Viszeralmedizin. 2015 Jun;31(3):166-72
pubmed: 26468310
Diagn Microbiol Infect Dis. 1993 Feb;16(2):119-22
pubmed: 8467622
J Infect. 2004 Feb;48(2):206-8
pubmed: 14720498
Tunis Med. 2015 Oct;93(10):602-5
pubmed: 26895121
Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011
pubmed: 18947320
J Accid Emerg Med. 1998 Jul;15(4):254-6
pubmed: 9681310
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16
pubmed: 29090866